• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Schrodinger Inc (NQ: SDGR )

17.99 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Schrodinger Inc

< Previous 1 2 3 4 5 Next >
Schrödinger to Announce Third Quarter 2024 Financial Results on November 12
October 31, 2024
From Schrödinger
Via Business Wire
Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium
October 23, 2024
From Schrödinger
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
October 17, 2024
From Schrödinger
Via Business Wire
Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium
October 09, 2024
From Schrödinger
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 18, 2024
From Schrödinger
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 16, 2024
From Schrödinger
Via Business Wire
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
August 14, 2024
From Schrödinger
Via Business Wire
Schrödinger Reports Strong Second Quarter 2024 Financial Results
July 31, 2024
From Schrödinger
Via Business Wire
Schrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive Toxicology
July 26, 2024
From Schrödinger
Via Business Wire
Schrödinger to Announce Second Quarter 2024 Financial Results on July 31
July 17, 2024
From Schrödinger
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 16, 2024
From Schrödinger
Via Business Wire
Simulations Plus Stock Drops 15% Despite EPS Beat
July 05, 2024
Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 14, 2024
From Schrödinger
Via Business Wire
Schrödinger to Present at Jefferies Global Healthcare Conference
May 22, 2024
From Schrödinger
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024
From Schrödinger
Via Business Wire
Schrödinger Reports First Quarter 2024 Financial Results
May 01, 2024
From Schrödinger
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 18, 2024
From Schrödinger
Via Business Wire
Schrödinger to Announce First Quarter 2024 Financial Results on May 1
April 10, 2024
From Schrödinger
Via Business Wire
Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting
March 20, 2024
From Schrödinger
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 19, 2024
From Schrödinger
Via Business Wire
Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results
February 28, 2024
From Schrödinger
Via Business Wire
Schrödinger to Participate in Upcoming Investor Conferences
February 20, 2024
From Schrödinger
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 16, 2024
From Schrödinger
Via Business Wire
Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28
February 14, 2024
From Schrödinger
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
January 19, 2024
From Schrödinger
Via Business Wire
Schrödinger Provides Update on Progress Across the Business and Outlines 2024 Development and Operational Goals
January 08, 2024
From Schrödinger
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 19, 2023
From Schrödinger
Via Business Wire
Schrödinger Highlights Progress of Clinical Programs and Discloses Three New Programs at First Therapeutics Pipeline Investor Event
December 14, 2023
From Schrödinger
Via Business Wire
Schrödinger Presents Data Supporting Advancement of SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting
December 10, 2023
From Schrödinger
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
November 17, 2023
From Schrödinger
Via Business Wire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap